INTRODUCTION
Focal therapy has been proposed as an alternative method to whole-gland treatment for prostate cancer. 1 Brachytherapy, using permanently implanted radioactive I-125 seeds, provides a method for treating prostate subvolumes with high doses of radiation whilst sparing healthy surrounding tissue. Various methods for defining these subvolumes have been proposed 2 and the results of a pilot study using a subvolume defined by biopsy and MRI with a "large safety margin" have recently been reported. 3 To minimize the amount of healthy tissue receiving a high radiation dose requires accurate tumor delineation. In addition, due to the multifocal nature of prostate cancer, even small tumors that demonstrate a high Gleason score may need to be incorporated into high dose regions to minimize the risk of local recurrence. 4 We have recently proposed and validated a radiobiological model which can be used to predict the radiation dose that is required to adequately treat prostate cancers. 5 This model requires knowledge of tumor location and tumor specific characteristics including tumor cell density (TCD), tumor proliferation which can be related to Gleason score (GS), and hypoxia (H). In order to apply this model clinically, in vivo multiparametric MRI (mpMRI) is required to give voxel level information about each of these parameters.
Various investigators have demonstrated the ability of mpMRI to predict tumor location, TCD, GS, and H through correlation with "ground truth" histology data. [6] [7] [8] [9] [10] [11] [12] Histological validation is important for interpretation and characterization of prostate tissue shown on MRI, as histological samples provide a direct visualization of cellular characteristics and tissue structure and can be scanned in color on a micrometer scale. In contrast, MR images are typically at millimeter resolution and the signal is an indirect representation of tissue structure determined by proton density and energy exchange between hydrogen nuclei, which is also influenced by sequence and machine specific parameters. Accurate registration of MRI with histology is therefore important and has benefits for various research and clinical applications including the following: improved targeting for image guided prostate biopsy; accurate cancer diagnosis, grading, and tumor localization; and for clinical trials to assess the performance of novel imaging methods.
Despite these benefits, many correlation studies of the prostate have been limited in their predictive power, due to uncertainties and simplistic assumptions in the registration of histology with mpMRI, 6, [9] [10] [11] [12] [13] and restriction to assessing the peripheral zone rather than the entire prostate gland. 7, 8 In a review paper by Meyer et al., 14 a number of approaches to registration of in vivo MRI and histology with assumptions that limit coregistration accuracy were described. These approaches included (1) simplistic visual correspondence of histology images with MRI slices and (2) registration of histology with manually or automatically selected corresponding in vivo MRI slices. While the second approach can adjust for in-plane deformation, neither approach is able to account for out-ofplane deformation caused by surgery or histological processing, and incorrectly assumes registration of prostate in vivo MRI with histology is less than a fully nonlinear 3D problem.
Studies that assume a direct slice correspondence between histology and in vivo MRI include that by Chappelow et al. 15 who developed an elastic registration technique using a multivariate formulation utilizing all mpMRI data to match with histology while Nir et al. 16 implemented a particle filtering framework to determine the optimal location of an imaging volume slice to match each histology image. In work by Turkbey et al., 17 custom molds were made for the prostate specimen using in vivo MR images, to guide pathological sectioning. In vivo MRI slices were then matched visually with histology, and misalignment was adjusted for by assessing neighboring regions.
To guide the registration of in vivo MRI with histology and adjust for out-of-plane deformation, imaging of the prostate specimen using ex vivo MRI or block face photos of the specimen is preferable.
14 Such approaches have often used fiducial markers in the specimen to facilitate reconstruction of histology or block face photos into 3D. 18, 19 In a study by Ward et al., 20 strand-shaped fiducial markers were placed on the prostate specimen and ex vivo 3D T2w MRI obtained, to determine the optimal cutting plane to match specimen sectioning with in vivo MRI slices. In work by Groenendaal et al., 7 three carbon rods were inserted into the prostate specimen and used to assist registration. Rigid and deformable registration methods were used to map the reconstructed specimen with in vivo MRI. Errors of 2-3 mm between MRI and histology were reported; however, a 5 mm margin was still required for MR tumor delineations to accurately correlate with tumors shown in histology. Recently, biomechanical modeling methods for registration purposes have been investigated. Studies by Nir et al. 21 and Samavati et al. 22 used magnetic resonance elastography data to derive material properties for deformable registration of in vivo MRI with ex vivo MRI. Average errors between in vivo MRI and histology between 2 and 3 mm were obtained and although results were promising, further investigation is required due to limited sample size.
In order to remove the need to rely on direct slice to slice correspondences, Park et al. developed a method to register MRI with histology using both block face photos and ex vivo MRI of the prostate specimen. Their method implemented multiple registration tasks, to take into account each aspect of tissue deformation including fixation and histology processing, without the use of fiducial markers in the prostate specimen. Deformable registration was implemented using mutual information and thin plate splines to register stacked block face photos with ex vivo MRI, and then subsequently to map ex vivo MRI with in vivo MRI. Errors between points in di↵usion MRI and histology of 3.74 and 2.26 mm were reported for two proof-of-concept patients. 23 In a later study, Park et al. presented results for mapping between MRI and 11 C-choline PET, again using ex vivo MRI. 24 Despite taking many aspects of deformation into account, this approach suffered from uncertainties regarding the slice thickness of the specimen sections relative to ex vivo MRI and utilized custommade software that was not freely available and di cult to run on modern platforms.
In our work, we aimed to implement and build upon the approach of Park et al., by similarly taking into account each aspect of prostate deformation via a series of registration tasks. We have treated the deformation between in vivo and ex vivo MRI as a 3D problem, without utilizing fiducials in the specimen to reduce interference with the prostate. In contrast to Park et al., however, we have not utilized block face photos but instead designed a custom sectioning box which we used on all specimens during ex vivo MRI scanning and to provide control over parallel tissue sectioning thickness. We have used open source and commonly used software to develop the framework, acquiring in vivo and ex vivo 3D T2w images and applying deformable registration to align them after implementing a novel step by convolving images with a Laplacian of Gaussian (LoG) filter to reduce noise and extract features to guide the registration. This registration step aimed to correct for tissue shrinkage and deformation after surgical removal. Ex vivo MR scanning included an axial T2w image at high in-plane resolution with slices we assumed matched histology sections. Each 2D histology image was registered with its corresponding ex vivo axial T2w image to account for formalin fixation and histology processing, initially aligned by using a similarity transform guided by matching control points, followed by an automatic registration. The following describes our developed framework in detail and provides metrics validating the approach.
METHODS
For this proof-of-concept study, we report on a sample set of six patients with biopsy proven prostate cancer scheduled for radical prostatectomy. Study approval was obtained from our institutional review board and informed consent was obtained from all patients.
2.A. Patient data
As detailed in Table I , patient age ranged from 55 to 71 years, pathological Gleason score 6-9, PSA 6.0-17.3 ng/ml, pathological T stage 2c to 3b. Presurgical mpMRI was carried out on all patients at least 4 weeks (range 30-93 days) postbiopsy and no more than 44 days (average 20 days) prior to surgical removal of the prostate. Surgical specimens were embedded in agarose gel and ex vivo MRI acquired within 24 h after prostatectomy. Whole mount histology sections were then obtained from the prostate specimen.
2.B. In vivo MR imaging
In vivo mpMRI data were collected for all patients based on the European Society of Urogenital Radiology (ESUR) guidelines 25 using a 3T Siemens Trio Tim machine (Siemens Medical Solutions, Erlangen, Germany). The protocol included T2w, di↵usion weighted imaging (DWI), and dynamic contrast-enhanced MRI (DCE-MRI), taking between 35 and 40 min of scanning time. A torso surface coil was used during data acquisition, without the use of an endorectal coil to minimize deformation of the prostate. An axial T2w image was acquired as per normal clinical protocol with an inplane resolution of 0.5 ⇥ 0.5 mm as shown in Fig. 1(a) (turbo spin-echo, T R/T E = 3500/96 ms, echo train length = 23, acquisition matrix = 320 ⇥ 320, FOV = 160 ⇥ 160 mm, slice thickness = 3 mm, intersection gap = 0.75 mm). In addition, a 3D T2w image was acquired at a resolution of 0.62 ⇥ 0.62 ⇥ 0.6 mm [turbo spin-echo, T R/T E = 750/(104-110) ms, echo train length = 21, acquisition matrix = 384 ⇥ 384, FOV = 240 ⇥ 240 mm] for the purpose of registration with ex vivo 3D T2w MRI.
2.C. Specimen preparation
After prostatectomy, specimens were formalin fixed, weighed, and surfaced inked as per routine clinical protocol. The specimen was placed into a custom-made sectioning box which contained slots every 5 mm to guide the pathologist's knife after ex vivo MR imaging (Fig. 2) . The prostate was positioned so that sections would be cut axially from the apex to the base and was fixed in place by embedding in agarose gel.
2.D. Ex vivo MR imaging
Two sets of ex vivo T2w images at di↵erent resolutions were acquired for each patient, (1) a 3D T2w dataset to register with in vivo 3D T2w data and (2) echo train length = 20, acquisition matrix = 448 ⇥ 312, FOV = 100 ⇥ 69.6 mm). For patients 4-6, the process of matching MRI slices to histology was aided by placing a MRIvisible fiducial marker between the location of the first and second cuts made in pathology. The ex vivo 3D T2w image dataset was then acquired at the same resolution as the in vivo 3D T2w images to use in coregistration; however, the option to interpolate the data in-plane before image reconstruction was selected in the scan protocol, resulting in an interpolated sampling interval with an apparent resolution of 0.31 ⇥ 0.31 ⇥0.6 mm [turbo spin-echo, T R/T E = 750/(110-117) ms, echo train length = 21, FOV = 172.5 ⇥ 200 mm, acquisition matrix = 268 ⇥ 320 mm with the "interpolate" function on].
2.E. Histopathology data
After ex vivo MR imaging, the prostate specimen was cut into 5 mm blocks using the knife-guiding slots in the sectioning box. Each 5 mm thick block was embedded in para n, and a 3 µm thick section was microtomed from the top surface of each block. Typically, a few sections of 20 µm required cutting from this top surface before a full face of tissue at 3 µm thickness could be obtained. Once a 3 µm thick section per block was acquired it was whole mounted on a 25⇥75 mm slide and stained with haematoxylin and eosin (H&E). Unmarked H&E slides were scanned on an Epson Perfection V700 scanner (Epson, Suwa, Japan) to give images at approximately 0.01 mm resolution [ Fig. 1(c) ].
An expert pathologist (CM) annotated tumor foci on each H&E slide, including the Gleason score, with a dark pen [ Fig. 1(d) ]. These annotated slides were also scanned on the Epson Perfection V700 scanner to provide a digitized image of the tumor location. Tumor annotations were wiped o↵ using alcohol, and peripheral zone outline annotations were drawn by the same pathologist with dark pen on the slides and scanned to give digitized histology images of the peripheral zone location.
2.F. Image registration overview
To combine image datasets from each patient into a single frame of reference, a series of image processing and registration tasks were carried out. A schematic showing how each image set was related is shown in Fig. 3 , where the ex vivo axial T2w MRI dataset was taken as the referent image.
2.G. In vivo MRI registration
The amount of movement between the in vivo axial and 3D MRI scans was minimal, as images were acquired during the same scanning session for each patient. Therefore, a rigid registration using the BRAINS registration module 26 with mutual information as the similarity metric in 3d slicer software (http://www.slicer.org) 27 was used due to the ease of implementation, to align the in vivo T2w MRI datasets. In cases where visual assessment of the registration was inadequate due to bladder filling or rectal motion, a manual rigid registration of the images was implemented.
2.H. In vivo to ex vivo MRI registration
To aid the challenging task of registering in vivo MRI to ex vivo MRI, images were preprocessed using a 3D LoG filter. The following steps describe the methods applied:
1. The prostate capsule was manually contoured on the axial T2w in vivo and ex vivo MR images by a radiation oncologist experienced in prostate contouring (SW) to provide a prostate mask. Each mask was then interpolated and resampled to match the resolution of the 3D Fig. 3 . Schematic demonstrating how MRI data and histology images are registered. The axial ex vivo T2w image for each patient forms the reference data set with which all other images are coregistered.
T2w datasets. Rigid registration was applied to align the prostate contour mask with the 3D T2w MRI before it was resampled; however, there was no movement of the specimen between the ex vivo axial and 3D scans, therefore registration was not required before the ex vivo mask image was resampled. 2. To ensure the registration was driven by dominant features within the prostate which were more likely visible on both in vivo and ex vivo MRI, both the in vivo and ex vivo 3D T2w MR images were convolved with a 3D LoG kernel using ImageJ. 28, 29 This kernel also had the e↵ect of reducing noise in the image data. The 3D LoG images were then cropped at the prostate contour boundary using the 3D mask images from step 1 (as shown in Fig. 4 ).
3. An initial manual alignment of the prostate between the in vivo 3D MRI and ex vivo 3D MRI data was applied using a 9 degree of freedom (DOF) transformation, which included rotation, translation, and scaling in some cases where shrinkage was seen, similar to that observed in a study by Orczyk et al. 30 who compared in vivo and ex vivo prostate volumes and shapes. A manual approach was preferred over an automatic method to provide more control over the alignment before deformable image registration (DIR) was applied. The in vivo 3D LoG filtered image was aligned with the ex vivo 3D MRI using the same 9 DOF transformation. 4. DIR was performed in 3D using an algorithm introduced by Rueckart et al. 31, 32 in cmtk software (http://www. nitrc.org/projects/cmtk) with the in vivo 3D LoG filtered and masked image as the moving image and the ex vivo 3D LoG filtered and masked image as the reference image. This involved a transformation model based on cubic spline interpolation between sparse, uniformly distributed control points and implemented a normalized mutual information similarity metric over the entire imaging volume. Parameters were chosen empirically and were the same across all patients, including a rigidity constraint to reduce unrealistic deformations. 5. Finally, the DIR transformation computed in step 4 was applied to the manually aligned in vivo 3D T2w MRI to deformably register it to ex vivo 3D T2w MRI.
2.I. Histology to ex vivo MRI registration
All histology to ex vivo MRI registration was carried out using matlab software (matlab 8.4, The MathWorks, Inc., Natlick, MA). First, annotated histology images with tumor markings and histology images including the peripheral zone markings were registered with the unannotated histology image using an intensity based rigid registration, with mutual information as the similarity metric. Since these images were obtained from the same histology slide, no deformation was required. Binary tumor and peripheral zone mask images were created from the annotated histology images in gimp software (GNU Image Manipulation Program) by manually tracing around the annotation lines and converting to masks. These mask images were registered with unannotated histology using the rigid transformation computed for the corresponding annotated histology image.
To register histology data with ex vivo MRI, we assumed each histology section matched an ex vivo axial T2w image due to the sectioning box design which provided matching of the slice orientation during scanning using the T1 coronal images. We also assumed that deformations of the histology sample during processing could be described by a nonreflective similarity transformation with rotation, translation, and uniform scaling. This method expected that any stretching of the tissue was uniform and was deemed appropriate 
To initialize the registration between histology and ex vivo MRI, control points were chosen by selecting features that were easily identifiable on both image sets. Features included the centre of cystic structures which were bright on T2w images and white on histology, the centre of the urethra and the ejaculatory ducts, and the boundaries of the prostate (see Fig. 5 ). A similarity transformation was then computed for each histology section, by minimizing the Euclidean distance between the selected control points. Automatic registration using mutual information and a similarity transformation was then applied to complete the alignment. Additional preprocessing was required to guide this automated registration step by applying a background threshold to mask the histology image, which was also applied to the ex vivo MR image to mask out the sectioning box and agar gel.
2.J. Registration validation
To quantify the registration performance between in vivo and ex vivo 3D T2w MRI, we computed the Dice coe cient of the prostate boundary contour between the initial manually aligned and deformably registered images. However, given that the manual prostate boundary contours contributed to the computed registration, we also sought to validate the approach by additional measures. For this, we computed errors between a set of corresponding ground-truth feature points annotated on the unregistered in vivo 3D T2w MR and ex vivo 3D T2w MR images by two independent observers, a radiation oncologist (SW) and a radiologist (BP). Mean distance between point feature correspondences were computed both after initial manual alignment and after DIR.
We also assessed the registration accuracy of the peripheral zone, as while this is the most common location for tumors in the prostate, it tended to contain few feature points which could drive the registration. In order to do this, we assessed the location of the peripheral zone on in vivo axial T2w MRI which were annotated by a radiologist (BP) and the peripheral zone boundaries annotated on each histology slide by a pathologist (CM). These annotations were registered with the referent ex vivo axial T2w image and compared.
The more simple registration processes between histology images and ex vivo MRI were assessed quantitatively by computing the distance between control points after registration and visually by considering tissue structures and the prostate boundary. This included the accuracy of the alignment of unannotated histology images with the following: (1) the annotated histology images (both the tumor location and peripheral zone images) and (2) the ex vivo MRI.
RESULTS
Registration was carried out on all six patients, despite di↵erences in prostate volume and severity of disease. Figure 6 shows the registration results for patient 2, demonstrating the deformed in vivo 3D T2w MRI data registered with histology and the nonlinear DIR map overlaid on the in vivo 3D T2w MRI.
3.A. In vivo to ex vivo MRI registration
Table II presents the dice coe cient values between the in vivo and ex vivo prostate contours before and after DIR. On average, the dice coe cient was 0.83 when images were manually aligned with scaling applied (0%-18%), while after DIR, the average dice coe cient increased to 0.93. Furthermore, each individual patient had an improved dice coe cient after DIR in comparison with the initial manual alignment, with a minimum of 0.91 and maximum of 0.94.
Average errors computed between corresponding feature points selected by the two separate annotators are given in Table III . Annotator 1 chose as many points as they could see, with an average of ten points per patient, distributed throughout the prostate and frequently at the edge of visible nodules and internal prostate boundaries. Annotator 2 aimed to choose five points per patient (except for patient 3 where they could only confidently select two points) that could be reliably identified in both data sets at the centre of hyperintense regions on the T2w images and were mostly in the transition zone where adenomatous structures were frequently present. Average feature point error based on those chosen by annotator 1 was 3.2 mm (SD 1.3 mm) after initial manual alignment and 3.2 mm (SD 1.6 mm) after DIR, while the average error from points chosen by annotator 2 was 4.1 mm (SD 1.4 mm) after initial manual alignment and 3.0 mm (SD 1.1 mm) after DIR. Overall, feature points selected by both annotators for patients 1, 4, 5, and 6 showed an improvement in image alignment after DIR with an average error of 3.8 mm (range 2.2-5.7 mm) for the initial manual alignment and 2.9 mm (range 2.0-5.1 mm) after DIR had been applied, while the average feature point error from both annotators between feature points for patient 3 was better before DIR. Patient 2, who had a large and aggressive tumor (see Table I ) had conflicting results. Feature points selected by annotator 1 demonstrated the error increased from an average 2.4 to 3.2 mm after DIR, while feature points from annotator 2 showed a large decrease in error from 5.1 to 1.4 mm.
Dice coe cient values between peripheral zone contours before and after DIR are given in Table II . The average peripheral zone dice coe cient was 0.69 (SD 0.13) after the initial manual alignment and 0.75 (SD 0.12) after DIR, giving an average improvement of 6%. Most patients demonstrated an increase in peripheral zone overlap, except for patient 2 whose dice coe cient value remained the same and patient 3 whose dice coe cient reduced from 0.77 to 0.76 after DIR. This particular patient had a small prostate with only three histology slides available to compute overlap statistics, the least of all cases, and the peripheral zone contour overlap improved for only one histology slide near the prostate base. Patient 2 boundaries were unclear due to the large tumor crossing the peripheral zone boundary and entering the transition zone which made both pathology and MRI annotations challenging.
3.B. Histology to ex vivo MRI registration
Qualitative assessment of the registration between histology images and ex vivo MRI demonstrated a good alignment of images. Quantitative assessment showed that the distance between control points after registration gave a mean distance of 0.57 mm (SD 0.28 mm, range 0.06-1.99 mm). The mean scaling required to register histology with ex vivo MRI was 106.7% (SD 4.3%). Scale factors ranged from 97.6% to 121.5%, with one slide each at the apex from patient 1 and patient 5 reducing in size after registration. Figure 5 (c) shows one example registered slice for patient 2, where the unannotated histology image and tumor mask are overlaid on the corresponding ex vivo MR image.
DISCUSSION
The aim of our study was to develop a registration framework to accurately map in vivo MRI with histology of the prostate using ex vivo MRI to provide an intermediate registration step. Whilst our sample size was small, our goal was to demonstrate that our registration methods were feasible across patients with prostates of di↵ering sizes and shapes, and di↵erent tumor volumes (see Table I ). Whilst registration can never be perfect, by using ex vivo MRI, we have ensured that a considerable number of prostate tissue deformation sources are accounted for. Furthermore, by acquiring in vivo and ex vivo 3D T2w images and convolving them with a LoG filter before applying deformable registration, we have developed a novel approach to align the prostate tissue before and after surgical removal. In contrast with a number of research groups who have simply mapped disease location by anatomical quadrant or investigated a section of the prostate such as the peripheral zone, our intent was to register MRI and histology of the entire prostate including tumor location and tumor biology, such as cell density, to give a voxel level representation of the entire gland.
Applying DIR to align the in vivo and ex vivo MR images was the most di cult task in the registration process, due to a number of inherent di culties. First, the same tissue structures often had quite a di↵erent appearance in the in vivo and ex vivo 3D T2w MR images, despite the use of near identical scanning protocols. For example, the prostate boundary appeared bright in ex vivo 3D images in contrast to the dark boundary observed in the in vivo 3D images. This is in part due to the di↵erence in water content between living and excised, formalin-fixed tissue. It is likely that use of the knee coil for the ex vivo imaging compared to the torso surface coil used for in vivo imaging also contributed to the di↵erence in MR signal. Second, once the prostate is removed, it undergoes considerable distortion compared to the in vivo shape. Formalin fixation causes tissue shrinkage, which is not necessarily uniform throughout the di↵erent tissues in the prostate. Furthermore, the side of the prostate positioned at the bottom of the bucket of fixative after surgery may cause flattening on one side of the prostate.
By using the prostate contour masks and applying a LoG filter to the 3D T2w data, we ensured the DIR was guided by the prostate boundary and also driven by dominant features within the prostate as the smaller features did not correspond well. During method development, we assessed di↵erent filters including Sobel and Gabor filters, as well as di↵erent metrics including normalized cross correlation. Normalized mutual information was selected as the similarity metric due the fast computational time (less than 1 h to solve), and to account for di↵erences in image brightness. We considered annotating additional features to further drive the registration including the peripheral zone boundary and the urethra; however, significant uncertainties in delineation rendered this process too subjective. Despite this, utilizing the LoG filter still ensured that prominent peripheral zone boundaries and urethra locations could be enhanced for registration. Results confirmed that the gross prostate volume matched more closely after DIR, demonstrated by the dice coe cient values for the prostate contour which increased for all study patients.
Selecting corresponding feature points to quantify the registration was a challenging task for both annotators, due to the limited resolution and partial volume e↵ects in MRI which caused di culties in defining the exact boundaries and centre points of spherical-type shapes and the di↵erent tissue appearance in the in vivo and ex vivo 3D scans. It was not possible to quantify the exact error inherent in defining these points; however, based on our 3D T2w image resolution, estimating an error of one voxel in the selection of a point would result in an error of 0.6 mm. By applying this estimated error margin of 0.6 mm in feature point position, we observed that registration of the large and feature-rich prostate from patient 4 improved after DIR based on points from both annotators, while the registration of patient 3 who had a small and relatively homogeneous prostate got worse after DIR. Patient 2 had contradictory results from each annotator, where the feature point error di↵erence was larger than the margin of 0.6 mm in both cases. Points from annotator 2 improved after DIR however annotator 1, who showed a worse feature point correspondence after DIR, found it particularly di cult to select feature points for this patient since there were a number of hyperintense features that were linear in shape rather than spherical so they could not always reliably identify the centre point.
The remaining three patients, patients 1, 5, and 6 all showed an improvement in feature point correspondence after DIR; however, the di↵erence in feature point error from annotator 1 was all below the margin of 0.6 mm (range 0.2-0.5 mm) while the di↵erence in error from annotator 1 all above the error margin (range 0.6-1.9 mm). In light of this, we compared the di↵erent methods used to select points by each annotator. Annotator 1 selected features in both the peripheral zone and transitional zone which frequently were located at the edge of visible nodules and prostate boundaries while annotator 2 mostly restricted point selection to the centre of hyperintense regions in the feature rich transitional zone. Based on the partial volume e↵ects in MRI, the centre points of hyperintense regions were expected to be more reliable than features located at nodule edges. Hence, we concluded that our DIR methodology improved the registration in prostates with many visible features on 3D T2w imaging, whereas it did not appear as e↵ective for prostates which were relatively homogeneous. In addition, it was di cult to validate registration accuracy in prostates with mostly linear rather than spherical shaped features.
Computing the overlap between peripheral zone regions provided an additional metric to assess the registration. While the average dice coe cient value increased from 0.69 to 0.75 after DIR, there was still a large portion of peripheral zone that did not overlap (i.e., 25%). The two main reasons for this were the following: (1) the peripheral zone is much easier to see on real tissue provided by histology in comparison with MRI, and (2) there were a number of interpolation and resampling steps required to transform the peripheral zone contour from in vivo axial T2w MRI to ex vivo axial MRI.
An estimate of the overall uncertainty between registered in vivo MRI and histology is possible by summing the mean errors in quadrature for each step in the registration process. The average distance between feature points from both annotators after DIR was 3.1 mm, which provides a 3D measure of error between in vivo and ex vivo MRI assuming there is no uncertainty associated with the selected feature points. The mean distance between control points on histology images and ex vivo MRI after automated registration was 0.57 mm, which provides an error estimate in the axial plane between these images. In order to estimate the uncertainty between ex vivo MRI and histology images in the out-of-plane direction, we have considered the pixel size on the T1 coronal images which were used to define the axial T2w MR image slice position. Since the T1 coronal images visualized the slots in the sectioning box across two pixels, equating to a thickness of 0.84 mm, we have conservatively rounded this value to predict an out-of-plane uncertainty of 1 mm. This also compensates for any error caused by microtome slicing during pathology processing which expected to be no more than 200 µm. Hence, when combining the 3D uncertainty vector lengths (in vivo to ex vivo and ex vivo to histology) in quadrature, we obtain a combined uncertainty estimate of 3.3 mm.
This estimated uncertainty is comparable to values reported by Park et al. 23 and marginally higher than errors of 2-3 mm reported by Groenendaal et al. 7 whose work was limited to the peripheral zone. Registration errors are typically incorporated into treatment margins for safe application of radiotherapy. Groenendaal et al., 7 for example, recommended a 5 mm margin be implemented for tumors predicted in the peripheral zone from mpMRI. Our work suggests similar sized margins would be required; however, we plan to implement a personalized margin based on a user defined risk strategy. Furthermore, our conservative implementation of focal therapy will ensure that regions of the prostate determined to be at low risk of containing cancer will still receive a low dose of radiation to account for small tumors not detected through imaging.
We are currently working to improve the quality of our in vivo and ex vivo 3D T2w MRI data to improve the images for coregistration which may further reduce the uncertainties. This includes removal of the in-plane interpolation of the ex vivo 3D T2w images before image reconstruction, to reduce data smoothing. Furthermore, a systematic investigation of parameters utilized during DIR will carried out, and the benefit of applying the LoG filter versus no filter will be quantitatively assessed for a larger cohort of patients. A limitation of this study is the amount of manual annotation required, including pathologist markup, the initial manual alignment of in vivo and ex vivo images before DIR, and the prostate contour annotation which introduces subjectivity and more preprocessing of data before registration. We aim to automate these processes where possible, which would speed up processing and computation times for each patient, which is currently between 1 and 2 days. We are also working towards semiautomating tumor delineation on histology data using a combination of pathologist mark-up and computer assisted methods 34, 35 which will be compared with tumor volumes in MRI defined by radiologists. Future work will include processing and image registration techniques to include features from histology such as cell density, 36 and mpMRI data including ADC maps from DWI, pharmacokinetic and parametric maps from DCE-MRI and R2* maps from BOLD MRI.
The ex vivo axial T2w MR image was selected as the reference dataset for each patient as this required no interpolation of the sparsely sampled histology data. In future, we will map all data to in vivo axial T2w MRI so we can develop an in vivo anatomical and biological atlas of the prostate from a growing database of patients. Using this atlas, along with Bayesian inferential techniques and inverse biological optimization methods, we intend to develop focal therapy treatment plans which will target known tumors while giving a reduced radiation dose to surrounding prostate tissue.
CONCLUSION
We have successfully developed a registration process for mapping in vivo MRI of the prostate to histology data implementing a number of processing steps and ex vivo MRI of the prostate specimen to improve accuracy. All six patients in our sample dataset were registered, by taking into account each aspect of prostate deformation via a series of registration tasks to give histology images and in vivo MRI in the ex vivo MRI frame of reference. Results demonstrated that our novel DIR methodology between in vivo and ex vivo MRI using 3D T2w images convolved with a LoG filter improved accuracy in comparison with a manual alignment for prostates containing features which were readily visible on 3D T2w MRI; however, it was challenging to validate whether DIR improved registration for prostates with few or mostly linear rather than spherical shaped features. Refinement of our MR imaging protocols to improve the data resolution and signal to noise ratio in the in vivo and ex vivo 3D T2w MR images, is currently underway and is expected to improve results. While the sample size was small, this framework provides a robust method which we will apply to future study patients in order to build an atlas of the prostate anatomy and tumor biology. Correlated data from an increasing database of patients will be used to inform a radiobiological model of the prostate, to enable MRI based planning for prostate focal therapy treatment.
